54
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Fomepizole (4-Methylpyrazole) in Fatal Methanol Poisoning with Early CT Scan Cerebral Lesions

, , , , , & show all
Pages 777-780 | Published online: 18 Nov 2004

REFERENCES

  • Burns M J, Graudins A, Aaron C K, McMartin K, Brent J. Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med 1997; 6: 829–832
  • Brent J, McMartin K, Phillips S. et al. Fomepizole for the treatment of ethylene glycol poisoning.Methylpyrazole for toxic alcohols study group. N Engl J Med 1999; 340(18)832–838
  • Jacobsen D, McMartin K E. Methanol and ethylene glycol poisonings. Mechanism of toxicity,clinical course, diagnosis and treatment. Med Toxicol 1986; 1: 309–334
  • Erlanson P, Fritz H, Hagstam K E, Liljeberg B, Tryding N, Voigt G. Severe methanol intoxication. Acta Med Scand. 1985; 177: 393–408
  • Jacobsen D, McMartin K E. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997; 35: 127–143
  • Aquilonius S M, Bergstrom K, Enoksson P, et al. Cerebral computed tomography in methanol intoxication. J Comput Assist Tomogr 1980; 4: 425–428
  • Kruse J A. Methanol poisoning. Intensive Care Med 1992; 18: 391–397
  • Hantson P, Duprez T, Mahieu P. Neurotoxicity to the basal ganglia shown by magnetic resonanceimaging following poisoning by methanol and other substances. J. Toxicol Clin Toxicol 1997; 35: 151–161
  • Jacobsen D, Sebastian C S, Barron S K, Carriere E W, McMartin K E. Effects of 4-methylpyrazole, methanol/ethylene glycol antidote,in healthy humans. J Emerg Med 1990; 8: 455–461
  • Jobard E, Harry P, Turcant A, Roy P M, Allain P. 4–methylpyrazole and hemodialysis in ethylene glycol poisoning. J Toxicol Clin Toxicol 1996; 34: 373–377
  • Phang P T, Passerini L, Mielke B, Berendt L, Garner E. Brain hemorrhage associated with methanol poisoning. Crit Care Med 1988; 16: 137–140
  • Rubinstein D, Escott E, Kellye J P. Methanol intoxication with putaminal and white matter necrosis:MR and CT findings. AJNRl 1995; 16: 1492–1494

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.